The business can plausibly compound well as
Gen-3 improves daily availability, more pilots convert into Assured subscriptions, and
sovereign programs add a second growth leg. But today’s valuation already prices in a lot of execution success. That means the likely path is strong revenue growth, some multiple compression, and a respectable rather than explosive equity outcome.